D5660c00004- A Phase 1B/2, Open-Label, Multicentre Study Assessing The Safety, Tolerability, Pharmacokinetics, And Preliminary Anti-Tumor Activity Of Medi4736 In Combination With Azd9150 Or Azd5069 In Patients With Advanced Solid Malignancies And Subseque
Posted Date: May 15, 2019
- Investigator: Trisha Wise-Draper
- Specialties: Cancer, Head and Neck Cancer, Oncology
- Type of Study: Drug
The main purpose of this study is to see if the AZD9150 and AZD5069 study drugs (alone or in combination with MEDI4736) shrink tumors like yours and by how much. This study is also being done to measure levels of the study drugs in the blood at different times and see how the body accepts and remov
Criteria:
To Be Eligible: Patient Must Be At Least 18 Years Of Age And Have Measurable Disease Of At Least 10 Mm. Nonpregnant And Nonnbreastfeeding.
Keywords:
Head And Neck, Cancer, Phase I, Solid Tumor
For More Information:
Uc Cancer Center
5135847698
cancer@uchealth.com